|
1
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar
|
|
2
|
Letourneau PA, Xiao L, Harting MT, Lally
KP, Cox CS Jr, Andrassy RJ and Hayes-Jordan AA: Location of
pulmonary metastasis in pediatric osteosarcoma is predictive of
outcome. J Pediatr Surg. 46:1333–1337. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brekken RA and Sage EH: Sparc a
matricellular protein: A crossroad of cell-matrix communication.
Med Sci Monit. 13:25–30. 2001.
|
|
4
|
Lane TF and Sage EH: The biology of SPARC,
a protein that modulates cell-matrix interactions. FASEB J.
8:163–173. 1994.PubMed/NCBI
|
|
5
|
Motamed K, Funk SE, Koyama H, Ross R,
Raines EW and Sage EH: Inhibition of PDGF-stimulated and
matrix-mediated proliferation of human vascular smooth muscle cells
by SPARC is independent of changes in cell shape or
cyclin-dependent kinase inhibitors. J Cell Biochem. 84:759–771.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Delany AM, Kalajzic I, Bradshaw AD, Sage
EH and Canalis E: Osteonectin-null mutation compromises osteoblast
formation, maturation, and survival. Endocrinology. 144:2588–2596.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Alford AI and Hankenson KD: Matricellular
proteins: Extracellular modulators of bone development, remodeling,
and regeneration. Bone. 38:749–757. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kunigal S, Gondi CS, Gujrati M, Lakka SS,
Dinh DH, Olivero WC and Rao JS: SPARC-induced migration of
glioblastoma cell lines via uPA-uPAR signaling and activation of
small GTPase RhoA. Int J Oncol. 29:1349–1357. 2006.PubMed/NCBI
|
|
9
|
Rentz TJ, Poobalarahi F, Bornstein P, Sage
EH and Bradshaw AD: SPARC regulates processing of procollagen I and
collagen fibrillogenesis in dermal fibroblasts. J Biol Chem.
282:22062–22071. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tai IT and Tang MJ: SPARC in cancer
biology: Its role in cancer progression and potential for therapy.
Drug Resist Updat. 11:231–246. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bradshaw AD and Sage EH: SPARC, a
matricellular protein that functions in cellular differentiation
and tissue response to injury. J Clin Invest. 107:1049–1054. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bellahcène A and Castronovo V: Increased
expression of osteonectin and osteopontin, two bone matrix
proteins, in human breast cancer. Am J Pathol. 146:95–100.
1995.PubMed/NCBI
|
|
13
|
Horie K, Tsuchihara M and Nakatsura T:
Silencing of secreted protein acidic and rich in cysteine inhibits
the growth of human melanoma cells with G arrest induction. Cancer
Sci. 101:913–919. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yunker CK, Golembieski W, Lemke N, Schultz
CR, Cazacu S, Brodie C and Rempel SA: SPARC-induced increase in
glioma matrix and decrease in vascularity are associated with
reduced VEGF expression and secretion. Int J Cancer. 122:2735–2743.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shi Q, Bao S, Maxwell JA, Reese ED,
Friedman HS, Bigner DD, Wang XF and Rich JN: Secreted protein
acidic, rich in cysteine (SPARC), mediates cellular survival of
gliomas through AKT activation. J Biol Chem. 279:52200–52209. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mateo F, Meca-Cortés O, Celià-Terrassa T,
Fernández Y, Abasolo I, Sánchez-Cid L, Bermudo R, Sagasta A,
Rodríguez-Carunchio L, Pons M, et al: SPARC mediates metastatic
cooperation between CSC and non-CSC prostate cancer cell
subpopulations. Mol Cancer. 13:2372014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheetham S, Tang MJ, Mesak F, Kennecke H,
Owen D and Tai IT: SPARC promoter hypermethylation in colorectal
cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC
expression and improve therapy response. Br J Cancer. 98:1810–1819.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen ZY, Zhang JL, Yao HX, Wang PY, Zhu J,
Wang W, Wang X, Wan YL, Chen SW, Chen GW, et al: Aberrant
methylation of the SPARC gene promoter and its clinical implication
in gastric cancer. Sci Rep. 4:70352014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mok SC, Chan WY, Wong KK, Muto MG and
Berkowitz RS: SPARC, an extracellular matrix protein with
tumor-suppressing activity in human ovarian epithelial cells.
Oncogene. 12:1895–1901. 1996.PubMed/NCBI
|
|
20
|
Zhang JL, Chen GW, Liu YC, Wang PY, Wang
X, Wan YL, Zhu J, Gao HQ, Yin J, Wang W, et al: Secreted protein
acidic and rich in cysteine (SPARC) suppresses angiogenesis by
down-regulating the expression of VEGF and MMP-7 in gastric cancer.
PLoS One. 7:e446182012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Notaro A, Sabella S, Pellerito O, Di Fiore
R, De Blasio A, Vento R, Calvaruso G and Giuliano M: Involvement of
PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells
to TRAIL-induced apoptosis. Int J Biol Sci. 10:466–478. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pellerito O, Notaro A, Sabella S, De
Blasio A, Vento R, Calvaruso G and Giuliano M: WIN induces
apoptotic cell death in human colon cancer cells through a block of
autophagic flux dependent on PPARγ down-regulation. Apoptosis.
19:1029–1042. 2014.PubMed/NCBI
|
|
23
|
Portanova P, Notaro A, Pellerito O,
Sabella S, Giuliano M and Calvaruso G: Notch inhibition restores
TRAIL-mediated apoptosis via AP1-dependent upregulation of DR4 and
DR5 TRAIL receptors in MDA-MB-231 breast cancer cells. Int J Oncol.
43:121–130. 2013.PubMed/NCBI
|
|
24
|
Tang MJ and Tai IT: A novel interaction
between procaspase 8 and SPARC enhances apoptosis and potentiates
chemotherapy sensitivity in colorectal cancers. J Biol Chem.
282:34457–34467. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sailaja GS, Bhoopathi P, Gorantla B,
Chetty C, Gogineni VR, Velpula KK, Gondi CS and Rao JS: The
secreted protein acidic and rich in cysteine (SPARC) induces
endoplasmic reticulum stress leading to autophagy-mediated
apoptosis in neuroblastoma. Int J Oncol. 42:188–196. 2013.
|
